β-Caryophyllene inhibits high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells.
Anti-Inflammatory Agents
/ pharmacology
Cell Proliferation
Cell Survival
Cells, Cultured
Extracellular Matrix
Glucose
Humans
Mesangial Cells
/ drug effects
NF-E2-Related Factor 2
/ genetics
NF-kappa B
/ metabolism
Oxidative Stress
/ drug effects
Polycyclic Sesquiterpenes
/ pharmacology
Reactive Oxygen Species
Diabetic nephropathy (DN)
Extracellular matrix (ECM)
Glomerular mesangial cells (MCs)
Oxidative stress
β-Caryophyllene
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
18
01
2020
revised:
30
04
2020
accepted:
30
04
2020
pubmed:
18
5
2020
medline:
12
3
2021
entrez:
17
5
2020
Statut:
ppublish
Résumé
β-Caryophyllene (BCP) is a bicyclic sesquiterpene compound that has anti-diabetic activity. However, the effect of BCP on diabetic nephropathy (DN) remains unclear. Here, we aimed to evaluate the potential role of BCP in high glucose (HG)-induced glomerular mesangial cells (MCs). MCs were maintained under HG condition to simulate DN in vitro. Our results showed that BCP inhibited HG-induced cell proliferation, ROS production and NADPH oxidase (NOX) 2/4 expression. BCP exhibited anti-inflammatory activity with decreased levels of TNF-α, IL-1β, IL-6 in HG-induced MCs. Moreover, BCP treatment suppressed the HG-induced secretion of fibronectin (FN) and collagen IV (Col IV) in MCs. Furthermore, BCP suppressed the NF-κB activation and enhanced the Nrf2 activation in HG-induced MCs. However, inhibition of Nrf2 attenuated the protective effects of BCP on HG-induced MCs, while inhibition of NF-κB enhanced the nephro-protective effects of BCP on MCs. In conclusion, these findings demonstrated that BCP executed protective effects on HG-induced MCs via regulating NF-κB and Nrf2 signaling pathways.
Identifiants
pubmed: 32416450
pii: S1567-5769(20)30177-6
doi: 10.1016/j.intimp.2020.106556
pii:
doi:
Substances chimiques
Anti-Inflammatory Agents
0
NF-E2-Related Factor 2
0
NF-kappa B
0
NFE2L2 protein, human
0
Polycyclic Sesquiterpenes
0
Reactive Oxygen Species
0
caryophyllene
BHW853AU9H
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
106556Informations de copyright
Copyright © 2020. Published by Elsevier B.V.